• Explore /
  • Poster
  • / Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.

Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial.

Abstract Poster

Authors

null

David P. Dearnaley

Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom

David P. Dearnaley , Clare Griffin , Isabel Syndikus , Vincent Khoo , Alison Jane Birtle , Ananya Choudhury , Catherine Ferguson , John Graham , Joe O'Sullivan , Miguel Panades , Yvonne L. Rimmer , Christopher D. Scrase , John Staffurth , Clare Cruickshank , Shama Hassan , Julia Pugh , Emma Hall

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

97182923

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 325)

Abstract #

325

Poster Bd #

A5

Abstract Disclosures

Similar Posters

First Author: David James Carpenter

First Author: Omar Y. Mian

First Author: Rupesh Kotecha

First Author: Christina H. Son